Toll Free: 1-888-928-9744

Endologix, Inc. (ELGX) - Product Pipeline Analysis, 2016 Update

Published: Jun 8, 2016 | Pages: 53 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company's AAA products are built on traditional minimally-invasive endovascular repair (EVAR) platform or endovascular sealing (EVAS) platform. The company's EVAR products include AFX endovascular AAA system Vela Proximal Endograft and Intuitrak endovascular AAA system; and EVAS products comprise Nellix endovascular aneurysm sealing system. It has manufacturing facility in Irvine. The company sells its products to hospitals in the US and Europe through direct sales force and through third-party international distributors and agents in other parts of the world.  Endologix is headquartered in California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Endologix, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 6 Endologix, Inc. Company Snapshot 7 Endologix, Inc. Company Overview 7 Endologix, Inc. Pipeline Products and Clinical Trials Overview 8 Endologix, Inc.- Pipeline Analysis Overview 10 Business Description 10 Key Facts 11 Endologix, Inc. - Major Products and Services 12 Endologix, Inc. Pipeline Products by Development Stage 13 Endologix, Inc. Clinical Trials by Trial Status 16 Endologix, Inc. Pipeline Products Overview 18 AFX2 Bifurcated Endograft System 18 AFX2 Bifurcated Endograft System Product Overview 18 AFX3 19 AFX3 Product Overview 19 AFX4 20 AFX4 Product Overview 20 Angulated Neck Stent Graft 21 Angulated Neck Stent Graft Product Overview 21 Nellix CHEVAS 22 Nellix CHEVAS Product Overview 22 Nellix EVAS System 23 Nellix EVAS System Product Overview 23 Nellix EVAS System Clinical Trial 24 Nellix With Snorkels 27 Nellix With Snorkels Product Overview 27 Nellix2 AAA Endovascular System 28 Nellix2 AAA Endovascular System Product Overview 28 Nellix2 AAA Endovascular System Clinical Trial 29 Ovation Alto System 30 Ovation Alto System Product Overview 30 Ovation iX Aortic Body 31 Ovation iX Aortic Body Product Overview 31 Ovation Prime Abdominal Stent Graft System 32 Ovation Prime Abdominal Stent Graft System Product Overview 32 Ovation Prime Abdominal Stent Graft System Clinical Trial 33 Ovation Thoracic Stent Graft System 35 Ovation Thoracic Stent Graft System Product Overview 35 Paravisceral System 36 Paravisceral System Product Overview 36 Ventana 2 37 Ventana 2 Product Overview 37 Ventana Fenestrated Stent Graft 38 Ventana Fenestrated Stent Graft Product Overview 38 Ventana Fenestrated Stent Graft Clinical Trial 39 Xpand BX Covered Stent 40 Xpand BX Covered Stent Product Overview 40 Endologix, Inc. - Key Competitors 41 Endologix, Inc. - Key Employees 42 Endologix, Inc. - Key Employee Biographies 43 Endologix, Inc. - Locations And Subsidiaries 44 Head Office 44 Other Locations & Subsidiaries 44 Recent Developments 45 Endologix, Inc., Recent Developments 45 May 26, 2016: Endologix Reports Positive Clinical Data from the Nellix EVAS FORWARD-IDE Study 45 May 16, 2016: Endologix Completes Patient Enrollment in the Ovation LIFE (Least Invasive Fast-Track EVAR) Study 45 May 09, 2016: Endologix Reports Results for the First Quarter 2016 46 Apr 28, 2016: Positive Nellix Clinical Data from the ASCEND Study for the Treatment of Juxta and Pararenal AAA Presented at the 38th Annual Charing Cross Symposium 47 Apr 27, 2016: Positive Nellix Clinical Data from the Global Registry and Treatment of Iliac Aneurysm Studies Presented at the 38th Annual Charing Cross Symposium 48 Apr 11, 2016: Endologix Announces CE Mark for Next-Generation Nellix EndoVascular Aneurysm Sealing System 49 Mar 08, 2016: Endologix Announces First Patients in Japan Treated With Nellix EndoVascular Aneurysm Sealing System 49 Feb 29, 2016: Endologix Announces First U.S. Commercial Implant of AFX2 Bifurcated Endograft System 50 Feb 22, 2016: Endologix Reports Results for the Fourth Quarter and Full Year 2015 50 Dec 10, 2015: Endologix AFX Endovascular AAA System Receives Shonin Approval for Marketing in Japan 51 Appendix 53 Methodology 53 About GlobalData 53 Contact Us 53 Disclaimer 53
List of Tables
Endologix, Inc. Pipeline Products and Clinical Trials Overview 8 Endologix, Inc. Pipeline Products by Equipment Type 8 Endologix, Inc. Pipeline Products by Indication 9 Endologix, Inc. Clinical Trials by Trial Status 9 Endologix, Inc., Key Facts 11 Endologix, Inc., Major Products and Services 12 Endologix, Inc. Number of Pipeline Products by Development Stage 13 Endologix, Inc. Pipeline Products Summary by Development Stage 14 Endologix, Inc. Clinical Trials by Trial Status 16 Endologix, Inc. Clinical Trials Summary 17 AFX2 Bifurcated Endograft System - Product Status 18 AFX2 Bifurcated Endograft System - Product Description 18 AFX3 - Product Status 19 AFX3 - Product Description 19 AFX4 - Product Status 20 AFX4 - Product Description 20 Angulated Neck Stent Graft - Product Status 21 Angulated Neck Stent Graft - Product Description 21 Nellix CHEVAS - Product Status 22 Nellix CHEVAS - Product Description 22 Nellix EVAS System - Product Status 23 Nellix EVAS System - Product Description 23 Nellix EVAS System - Aneurysm Study for Complex AAA: Evaluation of Nellix Durability 24 Nellix EVAS System - Clinical Relevance of Positron Emission Tomography (PET) Imaging Following Endovascular Aneurysm Repair Using the Nellix Endoprosthesis 24 Nellix EVAS System - Multicenter, Observational, Post-Market, Real World Registry to Assess Outcomes of Patients Treated with the Nellix System for Endovascular Abdominal Aortic Aneurysm Repair 25 Nellix EVAS System - Post-operative CT Follow up Measurement After Nellix Endoprosthesis Implantation in Patients with Abdominal Aortic Aneurysms 25 Nellix EVAS System - Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System: A Pivotal and Continued Access Study 26 Nellix With Snorkels - Product Status 27 Nellix With Snorkels - Product Description 27 Nellix2 AAA Endovascular System - Product Status 28 Nellix2 AAA Endovascular System - Product Description 28 Nellix2 AAA Endovascular System - Dynamic CT Imaging After Nellix Endoprosthesis Implantation 29 Ovation Alto System - Product Status 30 Ovation Alto System - Product Description 30 Ovation iX Aortic Body - Product Status 31 Ovation iX Aortic Body - Product Description 31 Ovation Prime Abdominal Stent Graft System - Product Status 32 Ovation Prime Abdominal Stent Graft System - Product Description 32 Ovation Prime Abdominal Stent Graft System - A Post-market Study to Evaluate the Safety and Performance of the Ovation or Ovation Prime Abdominal Stent Graft System 33 Ovation Prime Abdominal Stent Graft System - Least Invasive Fast-track EVAR with the Ovation Prime Abdominal Stent Graft System: LIFE Study 33 Ovation Prime Abdominal Stent Graft System - Least Invasive Fast-Track EVAR with the Ovation Prime Abdominal Stent Graft System: TriVascular Canadian LIFE Study 34 Ovation Prime Abdominal Stent Graft System - TriVascular Evaluation of Females Who are Underrepresented Candidates for Abdominal Aortic Aneurysm Repair (The LUCY Study) 34 Ovation Thoracic Stent Graft System - Product Status 35 Ovation Thoracic Stent Graft System - Product Description 35 Paravisceral System - Product Status 36 Paravisceral System - Product Description 36 Ventana 2 - Product Status 37 Ventana 2 - Product Description 37 Ventana Fenestrated Stent Graft - Product Status 38 Ventana Fenestrated Stent Graft - Product Description 38 Ventana Fenestrated Stent Graft - Prospective, Multicenter, Single Arm Safety and Effectiveness Trial of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms 39 Xpand BX Covered Stent - Product Status 40 Xpand BX Covered Stent - Product Description 40 Endologix, Inc., Key Employees 42 Endologix, Inc., Key Employee Biographies 43 Endologix, Inc., Subsidiaries 44


List of Figures
Endologix, Inc. Pipeline Products by Equipment Type 9 Endologix, Inc. Pipeline Products by Development Stage 13 Endologix, Inc. Clinical Trials by Trial Status 16

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over t

Read More...

Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmace

Read More...

Global adhesives & sealants market size is expected to reach USD 43.19 billion by 2020, as per a new research report by Radiant Insights, Inc. Strong demand from packaging, construction and automotive industries is expected drive adhesives and sealan

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...

Global PP (Polypropylene) nonwoven fabric market size is anticipated to be valued at USD 30.6 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing usage of hygiene products such as incontinence products and baby diapers is

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify